Abstract 5704
Background
This study determined whether online continuing professional development (CPD) activity could improve oncologists (Oncs) and obstetrician/gynaecologists (Obs/Gyns) competence and confidence in the use of CDK4/6I in practice.
Methods
An interactive text-based activity that included discussion of 2 detailed patient cases was launched for countries outside the United States in March 2017, with data collected until April 2017. Educational effect was assessed with a repeated-pairs pre-/post-assessment study design, where individual participants served as his/her own control. 3 multiple-choice, knowledge questions and 1 self-efficacy, 5-point Likert scale (confidence) question were analyzed. Chi-squared test assessed pre- to post-assessment change (5% significance level, P <.05). Magnitude of change in proportion of correct responses overall, and for each question, were determined with Cramer’s V (effect size: <0.05 none/minimal; 0.06-0.15 small, 0.16-0.30 medium, >0.30 large).
Results
204 Oncs and 51 Obs/Gyns completed both pre- and post-assessments. A large education effect was observed for both Oncs (V = 0.311) and Obs/Gyns (V = 0.459). At baseline, 46% of Oncs and 16% of Obs/Gyns answered all 3 questions correctly, increasing to 91% and 76%, respectively, post-assessment. An average of 75% of oncs selected the best response on pre-assessment (range, 66% to 80%), improving to 96% post-assessment (range, 96% to 97%). Statistically significant change for all 3 questions and a medium to large education effect was observed for the questions covering appropriate treatment selection, patient monitoring and management of neutropenia. Baseline understanding was lower for obs/gyns with a large education effect seen for all 3 questions. 38% of Oncs and 45% of Obs/Gyns reported increased confidence managing neutropenia due to CDK4/6I.
Conclusions
This on-demand, text-based activity with 2 interactive cases resulted in a significant, positive education effect. Baseline findings indicate that both specialties, would benefit from education to facilitate application of CDK4/6I in practice. Online medical education is important in supporting the practical application of new treatment regimens in practice.
Clinical trial identification
Legal entity responsible for the study
Medscape.
Funding
Pfizer.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2595 - Real-Life Utilization of Genomic testing for invasive Breast Cancer patients in Italy and France reduces Chemotherapy Recommendations
Presenter: Sandro Barni
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2343 - Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast
Presenter: Alexandre De Nonneville
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2990 - Baseline lymphocyte counts predict distant recurrence in early breast cancer
Presenter: Gun Min Kim
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4532 - A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure Invasive Lobular Breast Carcinoma (ILC).
Presenter: Luisa Carbognin
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2344 - Benefit of Adjuvant Systemic Therapies in HR+ HER2- pT1ab Node-Negative Breast Carcinomas
Presenter: Alexandre De Nonneville
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3525 - Anti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): an open-label, randomized, three-arm, multicenter, window-of-opportunity study
Presenter: Aleix Prat
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3908 - Clinicopathologic significance of androgen receptor expression and discordant receptor status during progression in breast cancer
Presenter: Chan Heun Park
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4075 - The outcomes of early breast cancers utilizing the Oncotype Dx Recurrence score (RS) instead of Clinico-pathological (CP) factors for prognostic risk assessment: A Single Institution Experience
Presenter: Adhar Alsayed
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
738 - Circulating tumor cells as a prognostic marker in non metastatic breast cancer patients.
Presenter: Summar Elmorshidy
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3151 - Molecular subtyping of breast cancer by dedicated breast PET
Presenter: Satoshi Sueoka
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract